Magnus Steigedal, PhD
Norwegian University of Science and Technology, Head of Department (IKOM) · Department of Clinical and Molecular Medicine, NTNU
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Magnus Steigedal, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:15 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07422597 · Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prostate CancerNorwegian University of Science and Technology · recruiting · Prostate Cancer · study chair
- Ph3NCT05223647 · Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung CancerNorwegian University of Science and Technology · terminated · Small-cell Lung Cancer · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:15 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.